checkAd

     246  0 Kommentare Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference - Seite 3

    Investor Relations:

    David Kugelman, President and CEO
    Atlanta Capital Partners, LLC
    (404) 856-9157 Office
    (866) 692-6847 Toll Free - U.S. & Canada
    dk@atlcp.com

    Lesen Sie auch

    Tony Schor, President
    Investor Awareness, Inc.
    (847) 971-0922
    tony@investorawareness.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Qualigen Therapeutics, Inc. to present at the Benzinga Biotech Small Cap Conference - Seite 3 CARLSBAD, Calif., March 18, 2021 (GLOBE NEWSWIRE) - Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that Michael Poirier, …